- Report
- February 2025
- 110 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- August 2024
- 96 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- March 2022
- 200 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- March 2022
- 180 Pages
Global
From €2202EUR$2,419USD£1,870GBP
€3146EUR$3,456USD£2,672GBP
- Book
- November 2019
- 440 Pages
- Book
- January 2022
- 400 Pages
- Book
- May 2021
- 560 Pages
- Book
- January 2021
- 400 Pages
- Book
- January 2018
- 384 Pages
- Book
- November 2017
- 628 Pages
- Book
- October 2018
- 488 Pages

Biomanufacturing is a sub-sector of biotechnology that focuses on the production of biopharmaceuticals, medical devices, and other products derived from living organisms. It involves the use of biotechnology processes such as genetic engineering, cell culture, and fermentation to produce these products. The biomanufacturing market is driven by the increasing demand for biopharmaceuticals, medical devices, and other products derived from living organisms. This demand is driven by the growing prevalence of chronic diseases, the increasing aging population, and the need for more effective treatments.
The biomanufacturing market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include Amgen, Merck, Novartis, Pfizer, and Roche. Other companies in the market include AbbVie, AstraZeneca, Biogen, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more